These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 19177684)

  • 1. Lipid control may require more than a statin. Additional medications or lifestyle changes may be necessary to lower total bad cholesterol and raise good cholesterol.
    Heart Advis; 2008 Nov; 11(11):6. PubMed ID: 19177684
    [No Abstract]   [Full Text] [Related]  

  • 2. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe: a turbocharger for the race to reach NCEP LDL goals.
    Lee S
    S D J Med; 2005 Oct; 58(10):435-6. PubMed ID: 16425945
    [No Abstract]   [Full Text] [Related]  

  • 4. Ezetimibe reduces low-density lipoprotein cholesterol (LDL-C) in renal transplant patients resistant to HMG-CoA reductase inhibitors.
    Chuang P; Langone AJ
    Am J Ther; 2007; 14(5):438-41. PubMed ID: 17890931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing face of dyslipidemia therapy.
    Banerjee AK
    Indian Heart J; 2008; 60(3):192-4. PubMed ID: 19240305
    [No Abstract]   [Full Text] [Related]  

  • 6. Should we change our lipid management strategies to focus on non-high-density lipoprotein cholesterol?
    Rana JS; Boekholdt SM
    Curr Opin Cardiol; 2010 Nov; 25(6):622-6. PubMed ID: 20852414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between achieving low-density lipoprotein cholesterol (LDL-C) goal and statin treatment in an employee population.
    Burton WN; Chen CY; Schultz AB; Edington DW
    Popul Health Manag; 2010 Feb; 13(1):1-8. PubMed ID: 20158317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids in health and disease.
    Shepherd J
    Biochem Soc Trans; 2004 Dec; 32(Pt 6):1051-6. PubMed ID: 15506961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LDL = 5: Virtues and dangers of multidrug therapy of low-density lipoprotein cholesterol.
    Phillips W; Schaefer S
    Prev Cardiol; 2010; 13(2):69-71. PubMed ID: 20377808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.
    Micallef MA; Garg ML
    J Nutr Biochem; 2009 Dec; 20(12):927-39. PubMed ID: 19733044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum lipid indices and statin consumption with periodontal status.
    Sayar F; Fallah S; Akhondi N; Jamshidi S
    Oral Dis; 2016 Nov; 22(8):775-780. PubMed ID: 27426870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can group medical clinics improve lipid management in diabetes?
    Crowley MJ; Melnyk SD; Ostroff JL; Fredrickson SK; Jeffreys AS; Coffman CJ; Edelman D
    Am J Med; 2014 Feb; 127(2):145-51. PubMed ID: 24462012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cardiovascular risk associated with both low density and high density lipoproteins using statin-niacin combination therapy.
    Duvall WL; Blazing MA; Saxena S; Guyton JR
    J Cardiovasc Risk; 2002 Dec; 9(6):339-47. PubMed ID: 12478203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: a randomized, placebo-controlled study.
    Schrott HG; Knapp H; Davila M; Shurzinske L; Black D
    Am Heart J; 2000 Aug; 140(2):249-52. PubMed ID: 10925339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of combined statin-fibrate treatment to monotherapy in patients with mixed hyperlipidemia.
    Kłosiewicz-Latoszek L; Szostak WB; Grzybowska B; Białobrzeska-Paluszkiewicz J; Wiśniewska B; Stolarska I
    Kardiol Pol; 2004 Jun; 60(6):567-77. PubMed ID: 15334157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with statins: lowering of cholesterol or more?].
    Rutishauser J
    Praxis (Bern 1994); 2006 Jan; 95(4):107-10. PubMed ID: 16485605
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal lipids, statins, and dementia.
    Lavie CJ; Milani RV
    J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
    [No Abstract]   [Full Text] [Related]  

  • 19. Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome.
    Denke M; Pearson T; McBride P; Gazzara RA; Brady WE; Tershakovec AM
    Diab Vasc Dis Res; 2006 Sep; 3(2):93-102. PubMed ID: 17058629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugs for lipids.
    Treat Guidel Med Lett; 2011 Mar; 9(103):13-20. PubMed ID: 21350395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.